The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Oral Session

Oral Session 3-12A CML: Clinical

Sun. Oct 14, 2018 8:30 AM - 9:30 AM No.12 (Osaka International Convention Center, 10F 1006-7)

Chair: Kaichi Nishiwaki (Division of Oncology and Hematology, Jikei University Kashiwa Hospital, Japan)

[OS3-12A-3] Optimal interval for detection of molecular relapse after stop of TKI in CMLBC

Koichi Miyamura1, Satoshi Nishiwaki2 (1.Dept. Hematology Japanese Red Cross Nagoya First Hospital, Nagoya, Japan, 2.Dept. Hematol&Oncol, Nagoya Univ., Nagoya, Japan)

Abstract password authentication.
Password is written on a program and abstract book.

Password